Life Sciences News
Undaunted by Wall Street “Penalty Box,” Keryx Focuses on Kidney Drug
Wireless Health Summit Showcases Incentive Prizes as Tool for Change
Sue Siegel Leaves MDV to Run $6B GE Health Unit
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
Page: 2 of 358
Email this to a friend
Post to Twitter
Share on Facebook
Powered by
